Home » Stocks » Medigus

Medigus Ltd. (MDGS)

Stock Price: $1.64 USD 0.02 (1.23%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
Pre-market: $1.56 -0.08 (-4.88%) Aug 10, 4:55 AM

Stock Price Chart

Key Info

Market Cap 12.56M
Revenue (ttm) 273,000
Net Income (ttm) -14.18M
Shares Out 7.66M
EPS (ttm) -3.62
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $1.64
Previous Close $1.62
Change ($) 0.02
Change (%) 1.23%
Day's Open 1.62
Day's Range 1.57 - 1.67
Day's Volume 135,292
52-Week Range 0.83 - 5.15

More Stats

Market Cap 12.56M
Enterprise Value 5.68M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 7.66M
Float 2.66M
EPS (basic) -0.9
EPS (diluted) -3.62
FCF / Share -0.19
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 50,953
Short Ratio 0.16
Short % of Float n/a
Beta 1.26
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 46.01
PB Ratio 1.85
Revenue 273,000
Operating Income -14.20M
Net Income -14.18M
Free Cash Flow -2.82M
Net Cash 6.88M
Net Cash / Share 0.90
Gross Margin -66.67%
Operating Margin -5,202.93%
Profit Margin -5,193.40%
FCF Margin -1,032.60%
ROA -21.36%
ROE -174.93%
ROIC -3,853.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$158.61*
Low
159
Current: $1.64
High
159
Target: 158.61
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014
Revenue0.270.440.470.550.620.74
Revenue Growth-37.39%-6.64%-14.94%-12.02%-16.13%-
Gross Profit-0.18-0.17-0.050.370.350.39
Operating Income-14.20-6.67-6.11-9.09-9.56-8.25
Net Income-14.18-6.60-2.55-9.01-9.53-6.36
Shares Outstanding75.9347.9511.048.607.104.88
Earnings Per Share-0.90-0.80-1.15-13.10-6.80-6.60
Operating Cash Flow-2.76-4.25-4.66-9.26-6.97-7.78
Capital Expenditures-0.06-0.01-0.01-0.03-0.08-0.07
Free Cash Flow-2.82-4.26-4.67-9.29-7.05-7.85
Cash & Equivalents7.0410.636.333.0010.3112.92
Total Debt0.15-----
Net Cash / Debt6.8810.636.333.0010.3112.92
Assets13.3311.247.214.7212.1414.29
Liabilities5.203.161.701.801.961.24
Book Value6.718.085.512.9310.1813.05
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Medigus Ltd.
Country Israel
Employees 20
CEO Liron Carmel

Stock Information

Ticker Symbol MDGS
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: MDGS

Description

Medigus Ltd., a medical device company, develops, produces, and markets minimally invasive endo-surgical tools and direct visualization technology in the United States, Europe, Asia, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also provides miniaturized digital video cameras and video processing equipment for use in medical applications, as well as industrial applications. Medigus Ltd. was founded in 1999 and is headquartered in Omer, Israel.